Risk of Drug-Drug Interactions in Patients With HIV and Cancer
As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.
As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.
A study of 3090 patients with HIV seen at a tertiary care hospital from June 2019 to June 2020 revealed a 1.8% prevalence of advanced chronic kidney disease, an approximately 4-fold increase from 2008-2010.
Here’s what clinicians and patients need to know.
Medical centers in 5 US cities are testing mobile health units as a way to bring services to individuals with opioid use disorder.
Twenty-five percent experienced CVD event during follow-up; risk up for ß-blocker use but not with calcium channel blockers, diuretics
The effect of HIV serostatus on brachial artery flow-mediated dilation strongly influenced by kidney function
Acute kidney injury developed in more than half of patients with HIV who were hospitalized with COVID-19 at a medical center in Bronx, New York.
A 34-year-old Hispanic man with HIV presented with gradual onset lower-extremity edema over the past 2 months. He was diagnosed with HIV 10 years earlier. What is the cause of his nephropathy?
Outcomes similar for HIV+, HIV− donors; trend toward higher rejection found for HIV+ donors.
A 72-year-old man was referred to a nephrology clinic because of an increase in creatinine from 1.2 to 2.2 mg/dL. He has a complicated medical history of neurogenic bladder, benign prostatic hyperplasia (BPH), HIV, and metastatic squamous cell carcinoma of the left mandible post resection. He underwent cisplatin-based chemotherapy and radiation 3 years previously. For the…